Shaoshui Chen Selected Research

aumolertinib

1/2022	AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations.
1/2022	Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaoshui Chen Research Topics

Disease

4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2014
3	Neoplasms (Cancer) 05/2020 - 05/2015
2	Exanthema (Rash) 01/2022 - 03/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022
1	Disease Progression 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Diarrhea 01/2022
1	Nausea 03/2020
1	Vomiting 03/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Esophageal Neoplasms (Esophageal Cancer) 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Ductal Carcinoma 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 05/2015
1	Thrombocytopenia (Thrombopenia) 03/2015
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2015
1	Anemia 03/2015
1	Brain Neoplasms (Brain Tumor) 03/2015
1	Alopecia (Baldness) 03/2015

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	Gefitinib (Iressa)FDA Link 01/2022 - 03/2015
2	aumolertinibIBA 01/2022 - 01/2022
1	Rituximab (Mabthera)FDA Link 12/2022
1	Cisplatin (Platino)FDA LinkGeneric 03/2020
1	AntiemeticsIBA 03/2020
1	fosaprepitant FDA Link 03/2020
1	Aprepitant (Emend)FDA Link 03/2020
1	LuciferasesIBA 01/2020
1	EnzymesIBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2015
1	hydroxysafflor yellow AIBA 05/2015
1	FlavonoidsIBA 05/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2015
1	OsteopontinIBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2022 - 03/2020
3	Drug Therapy (Chemotherapy) 05/2020 - 03/2015
2	Radiotherapy 01/2020 - 03/2015
1	Chemoradiotherapy 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2015
1	Conformal Radiotherapy 03/2015